JPH0276859A - Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole - Google Patents

Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole

Info

Publication number
JPH0276859A
JPH0276859A JP63240799A JP24079988A JPH0276859A JP H0276859 A JPH0276859 A JP H0276859A JP 63240799 A JP63240799 A JP 63240799A JP 24079988 A JP24079988 A JP 24079988A JP H0276859 A JPH0276859 A JP H0276859A
Authority
JP
Japan
Prior art keywords
methyl
thiomethyl
imidazole
aminoethyl
methylimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63240799A
Other languages
Japanese (ja)
Other versions
JPH0768222B2 (en
Inventor
Tsunemasa Ueno
上野 恒正
Koichi Yamamoto
光一 山本
Masao Kitano
北野 正雄
Yutaka Morimoto
豊 森本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shokubai Co Ltd
Original Assignee
Nippon Shokubai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP63101243A priority Critical patent/JPH01272570A/en
Application filed by Nippon Shokubai Co Ltd filed Critical Nippon Shokubai Co Ltd
Priority to JP63240799A priority patent/JPH0768222B2/en
Priority to US07/342,798 priority patent/US4916233A/en
Priority to KR1019890005523A priority patent/KR900016142A/en
Priority to EP19890304158 priority patent/EP0339970A3/en
Publication of JPH0276859A publication Critical patent/JPH0276859A/en
Publication of JPH0768222B2 publication Critical patent/JPH0768222B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the subject compound useful as an intermediate for cimetidine without producing by-product while quantitatively converting unreacted material by reacting 4-methylimidazole with an addition product of cysteamine and formaldehyde in a mineral acid at specific molar concentrations. CONSTITUTION:Reaction liquid produced by reacting 4-methylimidazole with an adduct of cysteamine and formaldehyde in a mineral acid is extracted from the reaction system while keeping the molar concentration of 4-methyl-5-[(2- aminoethyl)-thiomethyl]-imidazole in the reaction system to <=70mol% based on the sum of 4-methylimidazole and 4-methyl-5-[(2-aminoethyl)- thiomethyl]imidazole. The liquid containing 4-methyl-5-[(2-aminoethyl)- thiomethyl]-imidazole is separated from the reaction liquid. The residue is reused by recycling to the reaction system.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は4−メチル−5−[(2−アミノエチル)−チ
オメチル]−イミダゾールを製造する新規な製法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a novel process for producing 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole.

本発明で得られる4−メチル−5−[(2−アミノエチ
ル)−チオメチル]−イミダゾールはヒスタミンH2−
受容体拮抗剤として知られているシメチジンの合成中間
体として重要な用途を有する化合物である。
4-Methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole obtained in the present invention is histamine H2-
This compound has important uses as a synthetic intermediate for cimetidine, which is known as a receptor antagonist.

(従来の技術) 従来4−メチル−5−[(2−アミノエチル)−チオメ
チル]−イミタゾールを得る方法としては、 ■ 4−メチル−5−ヒドロキシルメチル−イミダゾー
ルを濃塩酸中でシステアミンと反応させる方法(特開昭
53=119867号)、および■ 濃塩酸中の4−メ
チルイミダゾールをシステアミン及びホルムアルデヒド
もしくはチアゾリジンと反応させる方法(特開昭54−
132568号)等が知られている。
(Prior art) Conventional methods for obtaining 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imitazole include: ■ Reacting 4-methyl-5-hydroxylmethyl-imidazole with cysteamine in concentrated hydrochloric acid. (Japanese Unexamined Patent Publication No. 119867), and (1) A method of reacting 4-methylimidazole in concentrated hydrochloric acid with cysteamine and formaldehyde or thiazolidine (Unexamined Japanese Patent Application No. 1983-119867).
No. 132568), etc. are known.

(発明が解決しようとする課題) 特開昭53−119867号の4−メチル−5−ヒドロ
キシルメチル−イミダゾールを濃塩酸中でシステアミン
と反応させる方法の欠点は4−メチル−5−ヒドロキシ
ルメチル−イミダゾールから出発することである。なぜ
ならば4−メチル−5−ヒドロキシルメチルーイミタゾ
ールは4−メチルイミダゾールを塩酸中でホルムアルデ
ヒドと、反応させる方法や、4−メチルイミダゾール−
5−カルボン酸エステルの還元等で得られるが煩雑な手
段を要し収率も低いという欠点を有する。
(Problems to be Solved by the Invention) The disadvantage of the method of reacting 4-methyl-5-hydroxylmethyl-imidazole with cysteamine in concentrated hydrochloric acid as disclosed in JP-A-53-119867 is that 4-methyl-5-hydroxylmethyl-imidazole It is to start from. This is because 4-methyl-5-hydroxylmethyl-imitazole is produced by a method of reacting 4-methylimidazole with formaldehyde in hydrochloric acid, or by a method of reacting 4-methylimidazole with formaldehyde in hydrochloric acid.
Although it can be obtained by reduction of 5-carboxylic acid ester, it has the disadvantage that it requires complicated means and the yield is low.

従来の特開昭54−132568号の濃塩酸中の4−メ
チルイミダゾールをシステアミン及びホルムアルデヒド
もしくはチアゾリジンと反応させる方法は従来の特開昭
53−119867号の4−メチル−5−しドロキシル
メチル−イミダゾールを濃塩酸中でシステアミンと反応
させる方法の改良方法として4−メチルイミダゾールか
ら一段で4−メチル−5−[(2−アミノエチル)−チ
オメチル]−イミダゾールを得る方法を開示している。
The conventional method of reacting 4-methylimidazole in concentrated hydrochloric acid with cysteamine and formaldehyde or thiazolidine as disclosed in JP-A No. 54-132,568 is different from the method of reacting 4-methyl-5-droxylmethyl- as disclosed in JP-A-53-119,867. As an improved method of reacting imidazole with cysteamine in concentrated hydrochloric acid, a method for obtaining 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole in one step from 4-methylimidazole is disclosed.

本発明者はこの4−メチルイミダゾール、システアミン
、ホルムアルデヒドの一括反応を詳しく解析したところ
、4−メチルイミダゾールの転化率に対する4−メチル
−5−[(2−アミノエチル)−チオメチル]−イミダ
ゾールの選択率の関係は図−1に示す通りであり、反応
の初期より逐次反応が起るため、選択率の低下が認めら
れた。
The present inventor analyzed in detail the batch reaction of 4-methylimidazole, cysteamine, and formaldehyde, and found that 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole was selected for the conversion rate of 4-methylimidazole. The relationship between the rates is shown in Figure 1, and since the reactions occur sequentially from the beginning of the reaction, a decrease in selectivity was observed.

このため反応液より生成物を単離しようとするときは未
反応原料の除去と共に副成物の除去か不可欠であり、生
成効率が低いと共に未反応原料の再使用が実質上不可能
であるという欠点が認められた。
For this reason, when trying to isolate a product from a reaction solution, it is essential to remove byproducts as well as unreacted raw materials, which results in low production efficiency and virtually impossible reuse of unreacted raw materials. Defects were recognized.

本発明者は従来の方法の欠点を改良すべく鋭意研究を行
なった結果、従来の方法である4−メチルイミダゾール
、システアミン、ホルムアルデヒドの一括反応に対し、
システアミンとホルムアルデヒドをあらかじめ混合させ
得た付加物と4−メチルイミダゾールの鉱・酸中での反
応すなわち二段反応を詳しく解析した結果、図−1に示
す通り反応系内の4−メチル−5−[(2−アミノエチ
ル)−チオメチル〕−イミダゾールのモル濃度が4−メ
チルイミダゾールと4−メチル−5−[(2−アミノエ
チル)−チオメチル]−イミダゾールを合せたモル数に
対し、70モル%に達するまで、即ち4−メチルイミダ
ゾールの転化率が70モル%に達するまでは生成物の4
−メチル−5−[(2−アミノエチル)−チオメチル]
−イミダゾールのほぼ選択率はほぼ定量的であることを
見い出した。
The present inventor conducted intensive research to improve the drawbacks of conventional methods, and as a result, compared to the conventional method of simultaneous reaction of 4-methylimidazole, cysteamine, and formaldehyde,
As a result of detailed analysis of the reaction between an adduct obtained by pre-mixing cysteamine and formaldehyde and 4-methylimidazole in mineral/acid, that is, a two-step reaction, we found that 4-methyl-5- The molar concentration of [(2-aminoethyl)-thiomethyl]-imidazole is 70 mol% with respect to the total number of moles of 4-methylimidazole and 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole. until the conversion of 4-methylimidazole reaches 70 mol%.
-Methyl-5-[(2-aminoethyl)-thiomethyl]
- It has been found that the selectivity of imidazole is almost quantitative.

(課題を解決するための手段) 本発明はシステアミンとホルムアルデヒドとの付加物を
鉱酸中で4−メチルイミダゾールと反応させ、4−メチ
ル−5−[(2−アミノエチル)−チオメチル]−イミ
ダゾール製造するに際し、反応系内の4−メチル−5−
[(2−アミノエチル)−チオメチル]−イミダゾール
のモル濃度が4−メチルイミダゾールと4−メチル−5
−[(2−アミノエチル)−チオメチル]−イミダゾー
ルを合せたモル数に対し、70モル%以下に保ちながら
反応液を反応系外へ抜き出し、反応液から4−メチル−
5” [(2−アミノエチル)−チオメチル]−イミダ
ゾールを含む液を分離し、残部は反応系へ再循環して用
いることを特徴とする4−メチル−5−[(2−アミノ
エチル)−チオメチル]−イミダゾールの製法に関する
ものである。
(Means for Solving the Problems) The present invention involves reacting an adduct of cysteamine and formaldehyde with 4-methylimidazole in a mineral acid to produce 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole. During production, 4-methyl-5-
The molar concentrations of [(2-aminoethyl)-thiomethyl]-imidazole are 4-methylimidazole and 4-methyl-5
-[(2-Aminoethyl)-thiomethyl]-Imidazole, the reaction solution is extracted out of the reaction system while keeping the total number of moles at 70 mol% or less, and 4-methyl-
5" [(2-aminoethyl)-thiomethyl]-imidazole-containing liquid is separated and the remainder is recycled to the reaction system for use. The present invention relates to a method for producing [thiomethyl]-imidazole.

本発明において、反応系内の4−メチル−5−[(2−
アミノエチル)−チオメチル]−イミダゾールのモル濃
度が4−メチルイミダゾールと4−メチル−5−[(2
−アミノエチル)−チオメチル]−イミダゾールを合せ
たモル数に対し、70モル%以下、好ましくは60〜4
0モル%に保つ意味は実質的に逐次反応による副成物を
生成させないことにありプロセス上特段の意味を有する
ものである。またこの反応系をこの条件に保つには連続
的反応においては反応器内での反応温度および反応液の
滞留時間の制御により行うことができる。またバッチ反
応の場合は反応の終了を意味する。
In the present invention, 4-methyl-5-[(2-
The molar concentrations of 4-methylimidazole and 4-methyl-5-[(2
-aminoethyl)-thiomethyl]-imidazole, 70 mol% or less, preferably 60 to 4
The purpose of maintaining the content at 0 mol % is to substantially prevent the production of by-products due to sequential reactions, and has a special meaning in terms of the process. In addition, in order to maintain the reaction system under these conditions, in a continuous reaction, the reaction temperature and residence time of the reaction solution in the reactor can be controlled. In the case of a batch reaction, it also means the end of the reaction.

本発明の方法で用いられる4−メチルイミダゾールは遊
離塩基または塩酸、臭化水素酸、硫酸、リン酸等の鉱酸
で中和した塩の状態で用いられる。
The 4-methylimidazole used in the method of the present invention is used in the form of a free base or a salt neutralized with a mineral acid such as hydrochloric acid, hydrobromic acid, sulfuric acid or phosphoric acid.

本発明の方法で用いられるシステアミンとホルムアルデ
ヒドとの付加物はシステアミンとホルムアルデヒドを等
モル常温で混合することにより容易に得ることができる
The adduct of cysteamine and formaldehyde used in the method of the present invention can be easily obtained by mixing equimolar amounts of cysteamine and formaldehyde at room temperature.

本発明の方法で用いられるシステアミンは遊離塩基また
は鉱酸塩として用いられる。
The cysteamine used in the method of the invention is used as a free base or as a mineral acid salt.

本発明の方法で用いられるホルムアルデヒドはホルムア
ルデヒドを30〜40重量%を含有する水78Mあるい
はバラホルムアルデヒドとして用いられる。
The formaldehyde used in the method of the present invention is used as water 78M containing 30 to 40% by weight of formaldehyde or as formaldehyde.

本発明の方法で用いられる鉱酸としては塩酸、臭化水素
酸などのハロゲン化水素酸や硫酸、リン酸等が使用でき
る。
The mineral acids used in the method of the present invention include hydrohalic acids such as hydrochloric acid and hydrobromic acid, sulfuric acid, and phosphoric acid.

原料の4−メチルイミダゾールに対して鉱酸は2〜8倍
モル、経済性および生産性の面からは2〜5倍モルの使
用量が好ましい。
The mineral acid is preferably used in an amount of 2 to 8 times the amount of 4-methylimidazole used as a raw material, and from the viewpoint of economy and productivity, it is preferably used in an amount of 2 to 5 times the amount of 4-methylimidazole.

また原料のシステアミンとホルムアルデヒドとの付加物
と4−メチルイミダゾールのモル比0゜9〜1.1であ
り、°好ましくは等モルである。
Further, the molar ratio of the raw material adduct of cysteamine and formaldehyde to 4-methylimidazole is 0.9 to 1.1, preferably equimolar.

本発明のシステアミンとホルムアルデヒドとの付加物を
鉱酸中で4−メチルイミダゾールと反応させる好ましい
方法としては、システアミンとホルムアルデヒドとの付
加物水溶液と、4−メチルイミダゾール塩酸塩水溶液を
鉱酸中に連続的に供給し、100〜180℃、好ましく
は120〜150℃の温度で反応を行なうのがよい6反
応液の滞留時間は鉱酸の量、濃度および反応温度により
異なるが通常30分〜10時間である。
A preferred method for reacting the adduct of cysteamine and formaldehyde of the present invention with 4-methylimidazole in a mineral acid is to continuously prepare an aqueous solution of the adduct of cysteamine and formaldehyde and an aqueous solution of 4-methylimidazole hydrochloride in a mineral acid. The reaction should be carried out at a temperature of 100 to 180°C, preferably 120 to 150°C.6 The residence time of the reaction solution varies depending on the amount and concentration of the mineral acid and the reaction temperature, but is usually 30 minutes to 10 hours. It is.

本発明で反応系外へ抜き出した反応液から生成物である
4−メチル−5−[(2−アミノエチル)−チオメチル
]−イミダゾールと未反応原料を分離する方法としては
、カラム分離法や電気透析法があるが、電気透析法が好
ましい。
In the present invention, methods for separating the product 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole and unreacted raw materials from the reaction solution extracted from the reaction system include column separation method and electric There are dialysis methods, but electrodialysis is preferred.

本発明で用いられる電気透析装!は通常用いられるもの
で陽イオン交換・膜と陰イオン交換膜を交互に多数配列
し、両端に一対の電極を配置したものである。陽極側に
陰イオン交換膜、陰極側に陽イオン交換膜の室では電離
した陽イオンが陰極に向って移動し、陽イオン交換膜を
透過し、隣室に移り陰イオン交換膜で透過を阻止される
。この際適当な交換膜たとえばAC−110(旭化成(
株)製)などを用いることにより生成物より分子量の小
さな原料は陽イオン交換膜を透過し、分子量の大きな生
成物である4−メチル−5−[(2−アミノエチル)−
チオメチル]−イミダゾールは透過を阻止され分離が行
なわれる。
Electrodialysis device used in the present invention! This is commonly used and consists of a large number of cation exchange membranes and anion exchange membranes arranged alternately, and a pair of electrodes arranged at both ends. In a chamber with an anion exchange membrane on the anode side and a cation exchange membrane on the cathode side, ionized cations move toward the cathode, pass through the cation exchange membrane, and move to the next chamber, where their permeation is blocked by the anion exchange membrane. Ru. At this time, a suitable exchange membrane such as AC-110 (Asahi Kasei) is used.
Co., Ltd.), raw materials with a lower molecular weight than the product pass through the cation exchange membrane, and the product with a larger molecular weight, 4-methyl-5-[(2-aminoethyl)-
thiomethyl]-imidazole is blocked from permeation and separated.

生成物4−メチル−5−[(2−アミノエチル)−チオ
メチル]−イミダゾールを含む内部液はそのまま次工程
に使用される。また必要なら内部液を濃縮後1−10パ
ノール等の貧溶媒中で晶析することにより結晶として得
ることができる。
The internal solution containing the product 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole is used as is in the next step. If necessary, crystals can be obtained by concentrating the internal solution and crystallizing it in a poor solvent such as 1-10 panol.

原料を含む外部液はそのまま又は適当な濃度りこ濃縮ま
たは希釈後反応系ヘリサイクルすることができる。
The external liquid containing the raw material can be recycled to the reaction system as it is or after being concentrated or diluted to an appropriate concentration.

(作 用) 本発明において、反応系内の4−メチル−5−[(2−
アミノエチル)−チオメチル]−イミダゾールのモル濃
度が4−メチルイミダゾールと4−メチル−5−[(2
−アミノエチル)−チオメチル]−イミダゾールを合せ
たモル数に対し、70モル%以下、好ましくは60〜4
0モル%に保ちながら反応液を反応系外へ抜き出すこと
は実質的に逐次反応による副成物を生成させないことに
あり、反応生成物である4−メチル−5−[(2−アミ
ノエチル)−チオメチル]−イミダゾールを高品質で得
られる。また該反応液から未反応原料を分離し、反応系
ヘリサイクルすることにより、未反応原料をほぼ定量的
に反応生成物に転化できる作用を有する。
(Function) In the present invention, 4-methyl-5-[(2-
The molar concentrations of 4-methylimidazole and 4-methyl-5-[(2
-aminoethyl)-thiomethyl]-imidazole, 70 mol% or less, preferably 60 to 4
The purpose of extracting the reaction solution out of the reaction system while maintaining it at 0 mol% is to substantially prevent the generation of byproducts due to sequential reactions, and the reaction product 4-methyl-5-[(2-aminoethyl) -Thiomethyl]-imidazole can be obtained in high quality. Furthermore, by separating unreacted raw materials from the reaction solution and recycling them to the reaction system, the unreacted raw materials can be almost quantitatively converted into reaction products.

(実 施 例) 次に、実施例により本発明を具体的に説明するが、これ
らは単なる例示であり、本発明がこれら実施例に限定さ
れるも−のではない。
(Examples) Next, the present invention will be specifically explained using Examples, but these are merely illustrative and the present invention is not limited to these Examples.

(参 考 例) 「システアミンとホルムアルデヒドとの1寸加物の合成
] 37重量%ホルムアルデヒド に、システアミン塩酸塩75重量%水溶液302gを3
0°C以下で加え、システアミンとホルムアルデヒドと
の付加物の水溶??N464gを得た。
(Reference example) "Synthesis of a one-dimensional compound of cysteamine and formaldehyde" Add 302 g of a 75% by weight aqueous solution of cysteamine hydrochloride to 37% by weight formaldehyde.
Is the adduct of cysteamine and formaldehyde dissolved in water by adding it below 0°C? ? 464 g of N was obtained.

実施例−1 36重量%塩酸811gに4−メチルイミダゾール16
4gと参考例で得られたシステアミンとホルムアルデヒ
ドとの付加物の水溶液464gを溶解した。この混合物
をオートクレーブ中、140°Cにて2時間加熱かく拌
しな。得られた反応液1439g中には4−メチル−5
− [ (2−アミノエチル)−チオメチル]ーイミダ
ゾール・二塩酸塩244g、4−メチルイミダゾール塩
酸塩118gの他原料および塩酸を含み、4−メチルイ
ミダゾールの転化率は50%であった。
Example-1 4-methylimidazole 16 to 811 g of 36 wt% hydrochloric acid
4g and 464g of the aqueous solution of the cysteamine-formaldehyde adduct obtained in Reference Example were dissolved. The mixture was heated and stirred in an autoclave at 140°C for 2 hours. 4-methyl-5 was contained in 1439 g of the obtained reaction solution.
- Contained 244 g of [(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride, 118 g of 4-methylimidazole hydrochloride, other raw materials, and hydrochloric acid, and the conversion rate of 4-methylimidazole was 50%.

つぎにこの反応液を内部液、水1000gを外部液、電
極液として5%硫酸ナトリウム水2りン擾を用い、イオ
ン交換11i[AC−110(旭化成(株)製]を用い
た電気透析装置にかけた。電気透析の途中で外部液を水
1000gに交換しさらに電気透析を行なった。
Next, this reaction solution was used as an internal solution, 1000 g of water was used as an external solution, and 5% sodium sulfate water was used as an electrode solution. During the electrodialysis, the external solution was replaced with 1000 g of water and further electrodialysis was carried out.

最終的に内部液として4−メチル−5− [ (2−ア
ミノエチル)−チオメチル]ーイミダゾール・二塩酸塩
170gおよび水624gよりなる液794gを得た.
また外部液として4−メチル−5− [ (2−アミノ
エチル)−チオメチル]ーイミタゾール・二塩酸塩74
g、4−メチルイミダゾール塩酸塩118gの他原料お
よび塩酸を含む液2640gを得た。
Finally, 794 g of a liquid consisting of 170 g of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride and 624 g of water was obtained as an internal liquid.
In addition, as an external liquid, 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imitazole dihydrochloride 74
2,640 g of a liquid containing 118 g of 4-methylimidazole hydrochloride, other raw materials, and hydrochloric acid was obtained.

得られた内部液は減圧上濃縮後、1−プロピルアルコー
ル中に投入し、析出した結晶をろ過、乾燥すると白色結
晶の4−メチル−5− [ (2−アミノエチル)−チ
オメチル]ーイミダゾール・二塩酸塩159gが得られ
た。
The obtained internal solution was concentrated under reduced pressure and poured into 1-propyl alcohol, and the precipitated crystals were filtered and dried to give white crystals of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole. 159 g of hydrochloride was obtained.

実施例−2 実施例−1で得られた外部液を減圧下1000gまで濃
縮した。この濃縮液に4−メチルイミダゾール56g、
システアミンとポルムアルデヒドとの付加物の水溶液1
62gおよび36重量%塩酸70gを加えオートクレー
ブ中、140℃、1時間30分反応させた。得られた反
応液中には4−メチル−5− [ (2−アミノエチル
)−チオメチル]ーイミダゾール・二塩酸塩245g、
4−メチルイミダゾール・塩酸塩117gの他原料およ
び塩酸を含み、1回目の反応液と同組成であった。この
反応液を実施例−1と同様に電気透析することにより4
−メチル−5−[(2−アミノエチル)−チオメチル]
ーイミダゾール・二塩酸塩170gおよび水620gよ
りなる内部液が得られた。外部液は減圧下濃組接次反応
に循環した。
Example-2 The external liquid obtained in Example-1 was concentrated to 1000 g under reduced pressure. 56 g of 4-methylimidazole,
Aqueous solution of cysteamine and pomaldehyde adduct 1
62 g and 70 g of 36% by weight hydrochloric acid were added and reacted in an autoclave at 140°C for 1 hour and 30 minutes. The resulting reaction solution contained 245 g of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride;
It contained 117 g of 4-methylimidazole hydrochloride, other raw materials, and hydrochloric acid, and had the same composition as the first reaction solution. By electrodialyzing this reaction solution in the same manner as in Example-1, 4
-Methyl-5-[(2-aminoethyl)-thiomethyl]
An internal solution consisting of 170 g of imidazole dihydrochloride and 620 g of water was obtained. The external solution was circulated to the concentrated sequential reaction under reduced pressure.

実施例−3 図−2において、導管1より90.8g/hでシステア
ミン塩酸塩75%水溶液、導管2より48、7g/hで
37重量%ホルムアルデヒド水溶液を混合槽3に供給し
、導管4を通して反応器5へ供給した。
Example 3 In Figure 2, a 75% aqueous solution of cysteamine hydrochloride was supplied from conduit 1 at a rate of 90.8 g/h, and a 37% by weight formaldehyde aqueous solution was supplied from conduit 2 at a rate of 48,7 g/h, and It was supplied to reactor 5.

一方導管6より49、2 g / hで4−メチルイミ
ダゾール・塩酸塩水溶液を106.8g/hで反応器5
へ供給した。
On the other hand, 4-methylimidazole hydrochloride aqueous solution was fed into reactor 5 at 49.2 g/h from conduit 6 at 106.8 g/h.
supplied to.

反応器5は140°Cに保持し、反応器5中の反応液の
滞留時間は2時間となるよう制御した。反応器5より導
管7を通して反応液を1397g/hで連続的に抜き出
した。ついで冷却器8で50°C以下まで冷却した。こ
の液には生成物である4−メチル−5−[(2−アミノ
エチル)−チオメチル]−イミダゾール・二塩酸塩17
.46重量%、4−メチルイミダゾール・塩酸塩8.4
8重量%の他原料および塩酸を含み、4−メチルイミダ
ゾールの転化率50%に相当しな、この液を導管9を通
して電極液として5%硫酸ナトリウム水溶液を用いてイ
オン交換膜[AC−110(旭化成(株)製]を使用し
た電気透析装置10の内部液として供給した。導管11
から水2346g/hを電気透析装置10の外部液とし
て供給し、電#l液としては5%硫酸ナトリウム、水金
溶液を用いた。導管12より726 g/hで、4−メ
チル−5−[(2−アミノエチル)−チオメチル]−イ
ミタゾール・二塩酸塩20.16重量%の濃度の液を得
た。
Reactor 5 was maintained at 140°C, and the residence time of the reaction liquid in reactor 5 was controlled to be 2 hours. The reaction solution was continuously extracted from the reactor 5 through the conduit 7 at a rate of 1397 g/h. Then, it was cooled down to 50°C or lower using a cooler 8. This solution contains the product 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride 17.
.. 46% by weight, 4-methylimidazole hydrochloride 8.4
This solution, which contains 8% by weight of other raw materials and hydrochloric acid and corresponds to a conversion rate of 50% of 4-methylimidazole, was passed through a conduit 9 to an ion exchange membrane [AC-110 ( [manufactured by Asahi Kasei Co., Ltd.] was supplied as an internal liquid of an electrodialysis device 10. Conduit 11
2,346 g/h of water was supplied as an external liquid to the electrodialyzer 10, and a 5% sodium sulfate and water gold solution was used as the electrolytic solution. A liquid having a concentration of 20.16% by weight of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imitazole dihydrochloride was obtained from conduit 12 at a rate of 726 g/h.

電気透析装置10で得た外部液は、導管13より301
7 g/hで抜き出し、濃縮器14へ供給して濃縮し、
4−メチル−5−[(2−アミノエチル)−チオメチル
]−イミダゾール・二塩酸塩6.71重量%、4−メチ
ルイミダゾール・塩酸塩8.15重量%の他、原料およ
び塩酸を含む液に調整し、導管15を通して1454g
/hで反応器5へ戻した。
The external liquid obtained from the electrodialyzer 10 is transferred from the conduit 13 to 301
7 g/h, supplied to the concentrator 14 and concentrated,
In addition to 6.71% by weight of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride and 8.15% by weight of 4-methylimidazole hydrochloride, a liquid containing raw materials and hydrochloric acid was added. Adjust and pass through conduit 15 to 1454g
/h and returned to reactor 5.

また導管12より得られる液100gを濃縮後、■−プ
ロピルアルコール150g中に投入し、析出した沈殿を
ろ過し、乾燥すると白色結晶の4−メチル−5−[(2
−アミノエチル)−チオメチル]−イミダゾール・二塩
酸塩19.2gが得られた。
After concentrating 100 g of the liquid obtained from conduit 12, it was poured into 150 g of -propyl alcohol, the precipitate was filtered, and when dried, white crystals of 4-methyl-5-[(2
19.2 g of -aminoethyl)-thiomethyl]-imidazole dihydrochloride was obtained.

(発明の効果) 本発明のシステアミンとホルムアルデヒドとの付加物を
鉱酸中で4′−メチルイミダゾールと反応させ、4−メ
チル−5−[(2−アミノエチル)−チオメチル]−イ
ミダゾール製造するに際し、反応系内の4−メチル−5
−[(2−アミノエチル)−チオメチル]−イミダゾー
ルのモル濃度が4−メチルイミダゾールと4−メチル−
5−[(2−アミノエチル)−チオメチル]−イミダゾ
ールを合せたモル数に対し、70モル%以下に保ちなが
ら反応液を反応系外へ抜き出すことは実質的に逐次反応
による副成物を生成させないことにあり、反応生成物で
あると4−メチル−5−[(2−アミノエチル)−チオ
メチル]−イミダゾールを高品質で容易に得られる0、
tた該反応液から未反応原料を分離し、反応系ヘリサイ
クルすることにより未反応原料をほぼ定量的に反応生成
物に転化できる0本発明は反応、分離、未反応原料の回
収再使用を含むプロセスを連続的に行なう方法を提供す
るものであり工業的に有利な方法である。
(Effect of the invention) In producing 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole by reacting the adduct of cysteamine and formaldehyde of the present invention with 4'-methylimidazole in a mineral acid. , 4-methyl-5 in the reaction system
-[(2-Aminoethyl)-thiomethyl]-imidazole has a molar concentration of 4-methylimidazole and 4-methyl-
Extracting the reaction solution from the reaction system while keeping the amount of 5-[(2-aminoethyl)-thiomethyl]-imidazole at 70 mol% or less with respect to the total number of moles actually generates byproducts due to sequential reactions. The reaction product 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole can be easily obtained in high quality.
By separating the unreacted raw materials from the reaction solution and recycling them to the reaction system, the unreacted raw materials can be almost quantitatively converted into reaction products.The present invention enables the reaction, separation, and recovery and reuse of the unreacted raw materials. This is an industrially advantageous method because it provides a method for continuously carrying out processes including the following.

【図面の簡単な説明】[Brief explanation of the drawing]

図−1において(1)の曲線は本発明システアミンとホ
ルムアルデヒドとの付加物を鉱酸中で4−メチルイミダ
ゾールと反応させ、4−メチル−5−[(2−アミノエ
チル)−チオメチル]−イミダゾールを製造する際の原
料の4−メチルイミダゾールの転化率に対する生成物4
−メチル−5−[(2−アミノエチル)−チオメチル]
−イミダゾールの選択率の変化を示す。また(2)の曲
線は従来の方法である濃塩酸中で4−メチルイミダゾー
ル、システアミン、ホルムアルデヒドを一括反応させる
方法における4−メチルイミダゾールの転化率と4−メ
チル−5−[(2−アミノエチル)−チオメチル〕−イ
ミダゾールの選択率の変化を示す図である。 図−2は本発明の一実施例を示す工程図である。 3 : 混合槽 5 : 反応器 8 : 冷却器 10 : 電気透析装置 14 : !A縮器 特許出願人   日本触媒化学工業株式会社図  −1 転化率(X)
In Figure 1, the curve (1) is obtained by reacting the adduct of cysteamine and formaldehyde of the present invention with 4-methylimidazole in a mineral acid. Product 4 for the conversion rate of 4-methylimidazole in the raw material when producing
-Methyl-5-[(2-aminoethyl)-thiomethyl]
- Shows the change in selectivity of imidazole. Curve (2) shows the conversion rate of 4-methylimidazole and 4-methyl-5-[(2-aminoethyl )-Thiomethyl]-imidazole selectivity change. FIG. 2 is a process diagram showing one embodiment of the present invention. 3: Mixing tank 5: Reactor 8: Cooler 10: Electrodialyzer 14: ! A condenser patent applicant Nippon Shokubai Kagaku Kogyo Co., Ltd. Figure-1 Conversion rate (X)

Claims (2)

【特許請求の範囲】[Claims] (1)システアミンとホルムアルデヒドとの付加物を鉱
酸中で4−メチルイミダゾールと反応させ、4−メチル
−5−[(2−アミノエチル)−チオメチル]−イミダ
ゾールを製造するに際し、反応系内の4−メチル−5−
[(2−アミノエチル)−チオメチル]−イミダゾール
のモル濃度が4−メチルイミダゾールと4−メチル−5
−[(2−アミノエチル)−チオメチル]−イミダゾー
ルを合せたモル数に対し、70モル%以下に保ちながら
反応液を反応系外へ抜き出し、反応液から4−メチル−
5−[(2−アミノエチル)−チオメチル]−イミダゾ
ールを含む液を分離し、残部は反応系へ再循環して用い
ることを特徴とする4−メチル−5−[(2−アミノエ
チル)−チオメチル]−イミダゾールの製法。
(1) When reacting the adduct of cysteamine and formaldehyde with 4-methylimidazole in mineral acid to produce 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole, the reaction system 4-methyl-5-
The molar concentrations of [(2-aminoethyl)-thiomethyl]-imidazole are 4-methylimidazole and 4-methyl-5
-[(2-Aminoethyl)-thiomethyl]-Imidazole, the reaction solution is extracted out of the reaction system while keeping the total number of moles at 70 mol% or less, and 4-methyl-
4-Methyl-5-[(2-aminoethyl)-, which is characterized in that the liquid containing 5-[(2-aminoethyl)-thiomethyl]-imidazole is separated and the remainder is recycled to the reaction system for use. Process for producing [thiomethyl]-imidazole.
(2)反応液から4−メチル−5−[(2−アミノエチ
ル)−チオメチル]−イミダゾールを含む液を分離する
方法が電気透析法である請求項1記載の方法。
(2) The method according to claim 1, wherein the method for separating the liquid containing 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole from the reaction liquid is electrodialysis.
JP63240799A 1988-04-26 1988-09-28 Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole Expired - Lifetime JPH0768222B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP63101243A JPH01272570A (en) 1988-04-26 1988-04-26 Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole
JP63240799A JPH0768222B2 (en) 1988-06-01 1988-09-28 Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole
US07/342,798 US4916233A (en) 1988-04-26 1989-04-25 Method for production of 4-methyl-5-(2-aminoethyl)-thiomethyl)-imidazole
KR1019890005523A KR900016142A (en) 1988-04-26 1989-04-26 Preparation of 4-methyl-5-[(2-aminoethyl) -thiomethyl] -imidazole
EP19890304158 EP0339970A3 (en) 1988-04-26 1989-04-26 Method for production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63-132833 1988-06-01
JP13283388 1988-06-01
JP63240799A JPH0768222B2 (en) 1988-06-01 1988-09-28 Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole

Publications (2)

Publication Number Publication Date
JPH0276859A true JPH0276859A (en) 1990-03-16
JPH0768222B2 JPH0768222B2 (en) 1995-07-26

Family

ID=26467308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63240799A Expired - Lifetime JPH0768222B2 (en) 1988-04-26 1988-09-28 Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole

Country Status (1)

Country Link
JP (1) JPH0768222B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049549A1 (en) * 2005-10-27 2007-05-03 Nisshinbo Industries, Inc. Method for producing fine particles of salt, hydroxide or oxide, and fine particles of salt, hydroxide or oxide produced by such method
WO2008044544A1 (en) * 2006-10-04 2008-04-17 Nisshinbo Industries, Inc. Fine particle of hydroxide and/or oxide and process for producing the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249773A (en) * 1988-05-31 1990-02-20 Nippon Shokubai Kagaku Kogyo Co Ltd Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249773A (en) * 1988-05-31 1990-02-20 Nippon Shokubai Kagaku Kogyo Co Ltd Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049549A1 (en) * 2005-10-27 2007-05-03 Nisshinbo Industries, Inc. Method for producing fine particles of salt, hydroxide or oxide, and fine particles of salt, hydroxide or oxide produced by such method
WO2008044544A1 (en) * 2006-10-04 2008-04-17 Nisshinbo Industries, Inc. Fine particle of hydroxide and/or oxide and process for producing the same

Also Published As

Publication number Publication date
JPH0768222B2 (en) 1995-07-26

Similar Documents

Publication Publication Date Title
KR102300703B1 (en) Solvent-free alkane sulfonation
JPH0276859A (en) Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole
JPS5829296B2 (en) Method for producing monomethylhydrazine
EP0339970A2 (en) Method for production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole
JPH0717614B2 (en) Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole
JPH0717613B2 (en) Method for producing 4-methyl-5-[(2-aminoethyl) -thiomethyl-imidazole
JPH0244472B2 (en)
JPH0239502B2 (en) MONOMECHIRUHIDORAJINNOKAISHUHOHO
US20240092732A1 (en) Process for producing taurine
JPS6357574A (en) Production of imidazoles
JPS6127979A (en) Preparation of hydroxyflavan compound
JPH04145040A (en) Production of dipentaerythritol
JPH01149771A (en) Production of 4-methylimidazole
US3205267A (en) Production of z,z,j,j-tetrachlorosuccin- ic dialdehyde monohydrate and an adduct thereof
JPH07101931A (en) Production of 2-aminoethylsulfonic acid
JPH07100699B2 (en) Process for producing 4-methylimidazole
JPH023676A (en) Production of aminoalkylthiol sulfate
EP0142023B1 (en) Process for producing dl-phenylalanine
KR910002281B1 (en) Process for the preparation of beta-resorcyclic acid
JPH07100698B2 (en) Process for producing 4-methylimidazole
JPH03275644A (en) Production of alpha-hydroxyisobutyric acid
JPH06184072A (en) Method for purifying alpha-hydroxyisobutyramide
JP2671458B2 (en) Method for producing 2,2,6,6-tetramethyl-4-oxopiperidine
JPH01149770A (en) Production of 4-methylimidazole
JPH06172283A (en) Production of alpha-hydroxyisobutyric acid amide